Cancer Aid
Techstars '17Camperdown, AU · 2 known investors
Find your way into Cancer Aid
Sign up to see every warm intro you have to Cancer Aid
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cancer Aid team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Osara Health (formerly CancerAid) provides digital support, education, and behavior change programs for people affected by cancer and their caregivers. The platform aims to improve clinical outcomes including quality of life, physical and mental health, and survival rates.
Also known as CancerAid PTY LTD · Osara Health
Founders & leadership
Investors · 2
How we know: Clinton Capital Partners's portfolio page · research · startupdaily.net · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Company profile
researched Sep 2026Osara Health, founded as CancerAid, provides digital and human-delivered support for people affected by cancer and for their caregivers. The original CancerAid mobile app allowed patients to store diagnosis and treatment details, access condition-specific medical information, track and manage symptoms and medication, keep a personal journal, nominate a care team and family members through a "Champions" feature, and connect with a community of patients and survivors. A clinician-facing dashboard, ClinicianLink, was added to feed patient-reported information back into hospital workflows used by nurses, oncologists and radiologists.
The current offering is organized around a Cancer Coach Program and a Cancer Caregivers Program, which pair participants with a trained health coach providing one-on-one support by confidential phone call, SMS or email, alongside evidence-based educational resources covering topics such as sleep, uncertainty, communicating with doctors, returning to normal activities, and managing relationships. A survivorship offering supports people after active treatment. Programs are sold to organizations — including hospitals, health systems, insurers, professional associations and employers — as well as being made available to eligible individuals. The team includes oncologists, allied health professionals and other subject-matter experts.
Founding story
CancerAid was founded in 2016 by a group of Sydney oncologists who saw an opportunity to make patients active participants in their own cancer care. Co-founders Raghav Murali-Ganesh and Nikhil Pooviah met at the Chris O'Brien Lifehouse cancer treatment centre in Sydney, where Pooviah was a resident working with Murali-Ganesh in radiation oncology. After reviewing existing patient tools such as scheduling apps, Pooviah built an early patient-facing symptom tracker and community portal that became the basis of the product; Martin Seneviratne is also identified as a co-founder.
Business model
Premium app features and programs are licensed to organizations — cancer hospitals, payers and pharmaceutical companies — to improve symptom management, reduce hospital admissions and improve patient quality of life, while the patient-facing product has been offered free to end users. The company anticipated six-figure licensing deals with hospital systems for access to its full toolkit, and today markets separate "Osara for Organizations" and "Osara for Individuals" tracks.
Licensing of premium app features and coaching programs to healthcare institutions, insurers, pharmaceutical companies and employers rather than charging patients.
Traction
Reported 20,000 patients on the app and use within 80 of the 200 largest U.S. health systems as of May 2018, and 40,000 users across 24 countries with about $500K trailing-twelve-month revenue on an investor profile. Early customers included 17 healthcare organizations such as Chris O'Brien Lifehouse Hospital, MetroRehab Hospital and Hong Kong's Integrated Oncology Center. Published outcome figures cited by the company include 66% of participants showing improved physical and mental health, a 7x increase in activity levels, a 97% customer satisfaction score, and improvements in fatigue (53%), pain (32%) and overall quality of life (32%), with 73% more likely to return to work and prior daily activities. Named organizational customers include MinterEllison and the Central Adelaide Local Health Network.
Latest developments
The business rebranded from CancerAid to Osara Health in June 2023. It has since launched a survivorship-focused extension of its Cancer Coach Program, published 2026 research reporting that 66% of participants showed improved physical and mental health, and is marking its tenth year with a public declaration campaign. The Android app received a maintenance release (version 1.30.0) on 30 July 2024.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company described itself as the leading cancer app in Australia, the US and the UK, with the app reported as being used in 80 of the 200 largest U.S. health systems as of 2018. It was named in a venture investor's portfolio commentary as having expanded into the US with a sevenfold increase in ARR over two years.
Content is individualized to the patient's specific diagnosis and treatment path and developed in conjunction with treating clinicians — for example distinguishing cardiac risk between right- and left-sided breast cancer radiotherapy — rather than offering generic information. The product combines software with named human health coaches, and the company positions its cancer-specific expertise against the general counselling offered by employee assistance programs. The patient-facing product has been free to end users, with revenue drawn from institutional licensees.
Technology
A consumer mobile application (Android and iOS) for cancer patients and caregivers offering diagnosis and treatment trackers, symptom and medication logging in real time or retrospectively, journaling, care-team sharing via the Champions feature, community forums and curated educational content. Enterprise-side technology includes the ClinicianLink dashboard embedded in Epic Systems EHR workflows and an integration with Apple HealthKit for wearables. Human health coaching delivered by phone, SMS and email complements the software.
Go-to-market
Sales are directed at organizations — hospitals and health systems, payers, pharma, associations and employers — which then make the programs available to their patients, members or employees; the website offers a demo request for organizations and an eligibility check for individuals. Distribution of the consumer app runs through mobile app stores. Accelerator programs (HCF Catalyst, the Cedars-Sinai/Techstars accelerator) provided early hospital access and customer relationships.
People living with or after a cancer diagnosis and their caregivers; institutional buyers including cancer hospitals and health systems, health insurers/payers, pharmaceutical companies, professional associations and employers offering workplace wellbeing benefits.
Geography
Founded and headquartered in Sydney, Australia, with listed locations including Camperdown and Eveleigh in New South Wales; a dedicated US subsidiary and New York and Los Angeles presence support expansion into the US market, and early international customers included Hong Kong. Users have been reported across 24 countries.
History
The company launched its app in 2016 after joining the HCF Catalyst accelerator in February of that year and testing the product across Australian cancer institutions. It closed a Series B round in October 2016 and won the Chengdu Innovate 2016 competition, earning the right to represent Australia in China. It later participated in an accelerator run by Cedars-Sinai in conjunction with Techstars, and in May 2018 announced integration of its patient-reported data into Epic Systems electronic health records at Cedars-Sinai in Los Angeles along with an Apple HealthKit integration. In June 2023 the company rebranded from CancerAid to Osara Health, describing the change as an evolution of brand and product scope rather than a change of mission, with continuity of service for existing members and partners. In 2025-2026 the company marked its tenth year.
Risks & controversies
Revenue depends on institutional licensing to hospitals, payers, pharmaceutical companies and employers rather than on end users, concentrating commercial risk in enterprise sales cycles. Reported outcome and satisfaction statistics originate from the company's own materials. Consumer app ratings on third-party stores are limited and low in volume.
Compiled by commissioned research from 9 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 8
launches, deals, and filingsMaintenance release fixing a crash when accessing certain features offline.
CancerAid states it was awarded Best Start up Creating Social Impact by Richard Branson of Virgin Group and Best Global Startup by Steve Wozniak, co-founder of Apple.
The company announced a name and brand change from CancerAid to Osara Health, with continuity of service for existing members and partners.
CancerAid's ClinicianLink dashboard was integrated into Epic Systems electronic health records at Cedars-Sinai in Los Angeles, the first U.S. hospital system to incorporate its patient self-reported data, alongside an Apple HealthKit integration.
The company said it was expanding in the United States through a dedicated subsidiary focused on the U.S. healthcare market.
The app launched roughly two months before October 2016 after onboarding 17 healthcare clients including Chris O'Brien Lifehouse Hospital, MetroRehab Hospital and Hong Kong's Integrated Oncology Center.
CancerAid joined the HCF Catalyst accelerator program and tested its product in cancer institutions across Australia.
CancerAid won the Chengdu Innovate 2016 competition, earning the opportunity to represent Australia in China.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 9
primary sources listed
- CancerAidcanceraid.com · web
9 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Cancer Aid do?
- Osara Health, formerly CancerAid, delivers app-based education, symptom tracking and health coaching for cancer patients and caregivers.
- Who founded Cancer Aid?
- Cancer Aid was founded by Akshat Saxena.
- Who are Cancer Aid's investors?
- Cancer Aid's investors include Clinton Capital Partners, Techstars.
- Where is Cancer Aid headquartered?
- Cancer Aid is headquartered in Camperdown, AU.

